Login / Signup

Safeguarding Mail-Order DNA Synthesis in the Age of Artificial Intelligence.

Stephanie BatalisCaroline SchuergerGigi Kwick GronvallMatthew E Walsh
Published in: Applied biosafety : journal of the American Biological Safety Association (2024)
Mandating mail-order DNA synthesis providers to screen DNA synthesis orders is a critical safeguarding step that should be taken as soon as possible. Over time, biological design tools will reduce the effectiveness of such a regulation and actions should be taken now to limit the negative impacts in the future.
Keyphrases
  • artificial intelligence
  • circulating tumor
  • cell free
  • single molecule
  • machine learning
  • big data
  • deep learning
  • randomized controlled trial
  • systematic review
  • high throughput
  • circulating tumor cells